MedPath

Painless Local Anaesthesia With Bicarbonate Admixture

Phase 2
Completed
Conditions
Local Infiltration
Anesthesia
Interventions
Registration Number
NCT03238625
Lead Sponsor
University of Zurich
Brief Summary

This study examines whether the injection of local anesthesia mixed with sodium bicarbonate in the ratio of 3:1 creates a less burning sensation and is as effective regarding the anesthetic effect as in the ratio of 9:1.

Detailed Description

Therefore the investigators compare two groups with 24 healthy individuals in each group in a cross-over study. One group receives four injections (two in each forearm) and one group receives only two injections (one in each forearm)

The four injections of group 1 are:

* IMP1: Lidocaine and sodium bicarbonate ratio 3:1

* IMP 2: Lidocaine and sodium bicarbonate ratio 9:1

* IMP 3: Lidocaine

* IMP 4: Sodium cloride 0.9% (=placebo)

The two injections of group 2 are IMP1 and IMP2.

After each injection the individual has to rate their pain sensation on a NRS scale and afterwards the anesthetic effect gets tested by a standardized laser application.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • healthy male or female individuals between 18 and 75 years
  • able to understand and speak German
  • able to follow the instructions

Exclusion criteria:

  • oversensitivity to lidocaine or other local anesthetics of amide type or sulfites

  • prone to bleeding, intake of aspirine or anticoagulation

  • pregnancy

  • skin on forearms with lesions (i.e. sunburn, wounds, eczema or other skin diseases)

    • previous participation at the same study
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Group 1Sodium cloride 0.9%Consisting of 24 individuals between 18 and 75 years, able to understand German, not pregnant, with no intolerance of local anesthetics, with intact skin and no skin diseases, not prone to bleeding or taking anticoagulation or aspirine. Intervention: Every individual receives four injections IMP1: Lidocaine and sodium bicarbonate ratio 3:1, IMP 2: Lidocaine and sodium bicarbonate ratio 9:1, IMP 3: Lidocaine, and IMP 4: Sodium cloride 0.9% (=placebo), namely two in every volar forearm, and has to rate the pain associated during the injection of the fluid, not the needle stitch. Afterwards the anesthetic effect on the four areals which got injected will be checked with a palomar laser after 5, 30, 60, 90, 120 and 180 minutes.
Group 2Sodium cloride 0.9%Consisting of 24 different individuals than those belonging to Group 1. Between 18 and 75 years, able to understand German, not pregnant, with no intolerance of local anesthetics, with intact skin and no skin diseases, not prone to bleeding or taking anticoagulation or aspirine. Intervention: Every individual receives two injections: IMP 3 Lidocaine, and IMP 4 Sodium cloride 0.9% (=placebo), namely one in every volar forearm, and has to rate the pain associated during the injection of the fluid, not the needle stitch. Afterwards the anesthetic effect on the two areals which got injected will be checked with a palomar laser after 5, 30, 60, 90, 120 and 180 minutes.
Group 1Lidocaine and sodium bicarbonateConsisting of 24 individuals between 18 and 75 years, able to understand German, not pregnant, with no intolerance of local anesthetics, with intact skin and no skin diseases, not prone to bleeding or taking anticoagulation or aspirine. Intervention: Every individual receives four injections IMP1: Lidocaine and sodium bicarbonate ratio 3:1, IMP 2: Lidocaine and sodium bicarbonate ratio 9:1, IMP 3: Lidocaine, and IMP 4: Sodium cloride 0.9% (=placebo), namely two in every volar forearm, and has to rate the pain associated during the injection of the fluid, not the needle stitch. Afterwards the anesthetic effect on the four areals which got injected will be checked with a palomar laser after 5, 30, 60, 90, 120 and 180 minutes.
Group 1LidocaineConsisting of 24 individuals between 18 and 75 years, able to understand German, not pregnant, with no intolerance of local anesthetics, with intact skin and no skin diseases, not prone to bleeding or taking anticoagulation or aspirine. Intervention: Every individual receives four injections IMP1: Lidocaine and sodium bicarbonate ratio 3:1, IMP 2: Lidocaine and sodium bicarbonate ratio 9:1, IMP 3: Lidocaine, and IMP 4: Sodium cloride 0.9% (=placebo), namely two in every volar forearm, and has to rate the pain associated during the injection of the fluid, not the needle stitch. Afterwards the anesthetic effect on the four areals which got injected will be checked with a palomar laser after 5, 30, 60, 90, 120 and 180 minutes.
Group 2LidocaineConsisting of 24 different individuals than those belonging to Group 1. Between 18 and 75 years, able to understand German, not pregnant, with no intolerance of local anesthetics, with intact skin and no skin diseases, not prone to bleeding or taking anticoagulation or aspirine. Intervention: Every individual receives two injections: IMP 3 Lidocaine, and IMP 4 Sodium cloride 0.9% (=placebo), namely one in every volar forearm, and has to rate the pain associated during the injection of the fluid, not the needle stitch. Afterwards the anesthetic effect on the two areals which got injected will be checked with a palomar laser after 5, 30, 60, 90, 120 and 180 minutes.
Primary Outcome Measures
NameTimeMethod
Rating of injection pain between IMP1 and IMP21 minute

on NRS scale

Secondary Outcome Measures
NameTimeMethod
rating of injection pain of IMP3 and IMP41 minute

on NRS scale

rating of clinical relevance of the difference between pain sensation of the injections5 minutes

participant can choose between four adjectives regarding injection pain:

* desirable

* acceptable

* less acceptable

* unacceptable

assessment of local anesthesia of each injection with a standardized laser90 minutes

with Palomoar Synosure non-ablative Fractional CO2-Laser with 30 mJ, 15 ms

duration of anesthetic effect of each injectionmaximum 90 minutes

with Palomoar Synosure non-ablative Fractional CO2-Laser with 30 mJ, 15 ms

Trial Locations

Locations (1)

University hospital, Department of Dermatology

🇨🇭

Zürich, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath